BioPharma, Pharma To focus on cancer, Chimerix sells rights to antiviral drug that defined the biotech By Frank Vinluan
BioPharma Chimerix starts Phase II/III trial of heparin-derived blood cancer drug in Covid-19 By Alaric DeArment
Policy, Health IT On Capitol Hill, CHIME, HIMSS push for cybersecurity leadership at HHS By Mark Taylor
Pharma Transplant antiviral strong in phase 2; Chimerix plans phase 3 start this year By Frank Vinluan
